Publications by authors named "Devika Gandhi"
Hepatic encephalopathy (HE) is a strong predictor of early hospital readmission in patients with cirrhosis. Early hospital readmission increases health care costs and is associated with worse survival. Herein we provide an overview of strategies to prevent hospital readmissions in patients with HE, divided into 3 contexts: (a) acute inpatient, (b) immediate postdischarge, and (c) longitudinal outpatient setting.
View Article and Find Full Text PDFVideo 1Use of endoscopic morcellator to assist in removal of stent.
View Article and Find Full Text PDFObjective: Weight loss interventions to treat obesity include sleeve gastrectomy (SG), lifestyle intervention (LI), endoscopic sleeve gastroplasty (ESG) and semaglutide. We aimed to identify which treatments are cost-effective and identify requirements for semaglutide to be cost-effective.
Design: We developed a semi-Markov microsimulation model to compare the effectiveness of SG, ESG, semaglutide and LI for weight loss in 40 years old with class I/II/III obesity.
Background & Aims: Gastric intestinal metaplasia (GIM) is associated with a higher risk of noncardia intestinal gastric adenocarcinoma (GA). The aim of this study was to estimate lifetime benefits, complications, and cost-effectiveness of GIM surveillance using esophagogastroduodenoscopy (EGD).
Methods: We developed a semi-Markov microsimulation model of patients with incidentally detected GIM, to compare the effectiveness of EGD surveillance with no surveillance at 10-year, 5-year, 3-year, 2-year, and 1-year intervals.
Article Synopsis
- Hepatic encephalopathy (HE) is a serious brain problem that can happen in people with liver disease, and it usually leads to bad health outcomes.
- The study looked at a tool called CAM-ICU, which helps check for delirium, and compared it to another method called West Haven Criteria to see how well it predicts patient outcomes.
- Results showed that people who tested positive with CAM-ICU had a much higher chance of dying in the hospital or within 30 to 90 days, showing that this tool is really good at identifying patients who are at risk.
Introduction: Clostridioides difficile infection (CDI) is common in patients with cirrhosis and is associated with poor outcomes. CDI risk factors in this population have been well characterized; however, risk factors of recurrent CDI (R-CDI) after treatment have not been explored. We sought to estimate the incidence of R-CDI and its associated risk factors in patients with cirrhosis.
View Article and Find Full Text PDF